Overactive Bladder - Results from #180

Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations. May 8, 2022

Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children. May 8, 2022

Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review. May 8, 2022

Barriers and facilitators to overactive bladder therapy adherence. May 8, 2022

Therapeutic efficacy and cognitive adverse events of overactive bladder medication in patients with central nervous system Disorders-A cohort study. May 1, 2022

Advances in Assistive Electronic Device Solutions for Urology. May 1, 2022

Overactivity index: A noninvasive and objective outcome measure in overactive bladder in children. May 1, 2022

Efficacy of non-pharmacological interventions in females with overactive bladder: A systematic review and network meta-analysis. April 24, 2022

Interplay between bladder microbiota and overactive bladder symptom severity: a cross-sectional study. April 17, 2022

Utilization rate and long-term persistence of combination pharmacotherapy with β3-agonists and antimuscarinics for overactive bladder refractory to monotherapy in a real-world setting. April 17, 2022

Noninvasive spinal neuromodulation mitigates symptoms of idiopathic overactive bladder. April 17, 2022

The Prevalence of Lower Urinary Tract Symptoms and Overactive Bladder in South Korea: A Cross-Sectional, Population-Based Study. April 10, 2022

Efficacy and safety of skin-adhesive low-level light therapy for overactive bladder: a Phase III study. April 10, 2022

Changes in overactive bladder medication following bariatric surgery: segmented regression analysis. April 10, 2022

Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment. April 3, 2022

Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder. April 3, 2022

The Impact of Caffeine Intake on Mental Health Symptoms in Postmenopausal Females with Overactive Bladder Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial. April 3, 2022

Resource use and healthcare costs in patients with overactive bladder who initiate treatment with mirabegron or antimuscarinic monotherapy in Catalonia: the MIRACAT study. March 27, 2022

Mirabegron for overactive bladder in frail patients 80 years or over (HOKUTO study). March 27, 2022

A Community-Based Education Program for Overactive Bladder in a Predominantly Minority Older Female Population: A Pilot Study. March 27, 2022

Page 10 of 109

SUFU MyBladder app